Design, synthesis, and biological evaluation of new urolithin amides as multitarget agents against Alzheimer's disease

Sadeleştirilmiş öğe sayfası
dc.contributor.authorShukur, Karar T.
dc.contributor.authorErcetin, Tugba
dc.contributor.authorLuise, Chiara
dc.contributor.authorSippl, Wolfgang
dc.contributor.authorSirkecioglu, Okan
dc.contributor.authorUlgen, Mert
dc.contributor.authorCoskun, Goknil P.
dc.contributor.authorYarim, Mine
dc.contributor.authorGazi, Mustafa
dc.contributor.authorGulcan, Hayrettin O.
dc.date.accessioned2025-10-16T15:19:52Z
dc.date.issued2021
dc.identifier.doi10.1002/ardp.202000467
dc.identifier.otherWOS:000612620800001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/7420
dc.publisherWILEY-V C H VERLAG GMBH
dc.sourceARCHIV DER PHARMAZIE
dc.subjectAlzheimer's disease
dc.subjectamyloid beta
dc.subjectantioxidant
dc.subjectcholinesterase
dc.subjectMAO\\-B
dc.subjecturolithins
dc.titleDesign, synthesis, and biological evaluation of new urolithin amides as multitarget agents against Alzheimer's disease
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS